Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
CareStream

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 26 November 1999:
Vol. 286. no. 5445, p. 1655
DOI: 10.1126/science.286.5445.1655a
Prev | Table of Contents | Next

News of the Week

BIOTECH PATENTS:
Genentech, UC Settle Suit for $200 Million

Marcia Barinaga

SAN FRANCISCO--Last week, South San Francisco biotech pioneer Genentech agreed to pay the University of California (UC) $200 million to settle a long-running patent suit. UC and Genentech were locked in a court battle over UC's claim that the company's $2 billion drug, Protropin, had infringed its patent on engineered human growth hormone. The deal, which includes a $50 million donation toward a research building at UC San Francisco--the campus that holds the disputed patent--will result in payments of $17 million each to five former UCSF scientists.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)